Prognosis in Budd Chiari syndrome after re-establishing hepatic venous drainage

Gut

Volumn 55, Issue 6, 2006, Pages 761-763

  Valla, D C ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ANGIOPLASTY; BUDD CHIARI SYNDROME; CLINICAL TRIAL; FOLLOW UP; HEPATIC VEIN; HUMAN; INFERIOR CAVA VEIN; INFERIOR CAVA VEIN OBSTRUCTION; INTERVENTIONAL RADIOLOGY; LIVER VEIN OBSTRUCTION; NOTE; PORTAL HYPERTENSION; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROGNOSIS; RARE DISEASE; RECANALIZATION; SHUNTING; SURGICAL RISK;

ANGIOPLASTY, BALLOON; HEPATIC VEIN THROMBOSIS; HEPATIC VEINS; HUMANS; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROGNOSIS; RADIOLOGY, INTERVENTIONAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33646794375     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2005.078048     Document Type: Note

References (24)

1. Janssen HL, Garcia-Pagan JC, Elias E, et al. Budd-Chiari syndrome: a review by an expert panel. J Hepatol 2003;38:364-71.
2. de Franchis R. Evolving Consensus in Portal Hypertension Report of the Baveno IV Consensus Workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2005;43:167-76.
3. Zitter M. Managing drugs for rare genetic diseases: trends and insights. Manag Care. 2005;14:52-4, 57-60, 63-4).
4. Valla D. Hepatic venous outflow tract obstruction etipathogenesis: Asia versus the West. J Gastroenterol Hepatol 2004;19:S204-11.
5. Eapen CE, Velissaris D, Heydtmann M, et al. Favourable medium term outcome following hepatic vein recanalisation and/or transjugular intrahepatic portosystemic shunt for Budd Chiari syndrome. Gut 2006;55:878-84.
6. Chunqing Z, Lina F, Guoquan Z, et al. Ultrasonically guided percutaneous transhepatic hepatic vein stent placement for Budd-Chiari syndrome. J Vasc Interv Radiol 1999;10:933-40.
7. Zhang CQ, Fu LN, Xu L, et al. Long-term effect of stent placement in 115 patients with Budd-Chiari syndrome. World J Gastroenterol 2003;9:2587-91.
8. Xu PQ, Dang XW. Treatment of membranous Budd-Chiari syndrome: analysis of 480 cases. Hepatobiliary Pancreat Dis Int 2004;3:73-6.
9. Kohli V, Ponde GK, Dev V, et al. Management of hepatic venous outflow obstruction. Lancet 1993;342:718-22.
10. Okuda K. Inferior vena cava thrombosis at its hepatic portion (obliterative hepatocavopathy). Semin Liver Dis 2002;22:15-26.
11. Tavill AS, Wood EJ, Kreel L, et al. The Budd-Chiari syndrome: correlation between hepatic scintigraphy and the clinical, radiological, and pathological findings in nineteen cases of hepatic venous outflow obstruction. Gastroenterology 1975;68:509-18.
12. Fisher NC, McCafferty I, Dolapci M, et al. Managing Budd-Chiari syndrome: a retrospective review of percutaneous hepatic vein angioplasty and surgical shunting. Gut 1999;44:568-74.
13. Valla D, Hadengue A, el Younsi M, et al. Hepatic venous outflow block caused by short-length hepatic vein stenoses. Hepatology 1997;25:814-19.
14. Hadengue A, Poliquin M, Vilgrain V, et al. The changing scene of hepatic vein thrombosis: recognition of asymptomatic cases. Gastroenterology 1994;106:1042-7.
15. Hernandez-Guerra M, Turnes J, Rubinstein P, et al. PTFE-covered stents improve TIPS patency in Budd-Chiari syndrome. Hepatology 2004;40:1197-202.
16. Perello A, Garcia-Pagan JC, Gilabert R, et al. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy. Hepatology 2002;35:132-9.
17. Ryu RK, Durham JD, Krysl J, et al. Role of TIPS as a bridge to hepatic transplantation in Budd-Chiari syndrome. J Vasc Interv Radiol 1999;10:799-805.
18. Mancuso A, Fung K, Mela M, et al. TIPS for acute and chronic Budd-Chiari syndrome: a single-centre experience. J Hepatol 2003;38:751-4.
19. Ganger DR, Klapman JB, McDonald V, et al. Transjugular intrahepatic portosystemic shunt (TIPS) for Budd-Chiari syndrome or portal vein thrombosis: review of indications and problems. Am J Gastroenterol 1999;94:603-8.
20. Attwell A, Ludkowski M, Nash R, et al. Treatment of Budd-Chiari syndrome in a liver transplant unit, the role of transjugular intrahepatic portosystemic shunt and liver transplantation. Aliment Pharmacol Ther 2004;20:867-73.
21. Cejna M, Peck-Radosavljevic M, Schoder M, et al. Repeat interventions for maintenance of transjugular intrahepatic portosystemic shunt function in patients with Budd-Chiari syndrome. J Vasc Interv Radiol 2002;13:193-9.
22. Rossle M, Olschewski M, Siegerstetter V, et al. The Budd-Chiari syndrome: outcome after treatment with the transjugular intrahepatic portosystemic shunt. Surgery 2004;135:394-403.
23. Zeitoun G, Escolano S, Hadengue A, et al. Outcome of Budd-Chiari syndrome: a multivariate analysis of factors related to survival including surgical portosystemic shunting. Hepatology 1999;30:84-9.
24. Murad SD, Valla DC, de Groen PC, et al. Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology 2004;39:500-8.